Glucose-6-phosphate dehydrogenase deficiency pathophysiology: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Xyz}} | |||
{{CMG}}; {{AE}} | |||
==Overview== | |||
The exact pathogenesis of [disease name] is not fully understood. | |||
OR | |||
It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3]. | |||
OR | |||
[Pathogen name] is usually transmitted via the [transmission route] route to the human host. | |||
OR | |||
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell. | |||
OR | |||
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells]. | |||
OR | |||
The progression to [disease name] usually involves the [molecular pathway]. | |||
OR | |||
The pathophysiology of [disease/malignancy] depends on the histological subtype. | |||
==Pathophysiology== | |||
===Physiology=== | |||
The normal physiology of [name of process] can be understood as follows: | |||
===Pathogenesis=== | |||
*The exact pathogenesis of [disease name] is not completely understood. | |||
OR | |||
*It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3]. | |||
*[Pathogen name] is usually transmitted via the [transmission route] route to the human host. | |||
*Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell. | |||
*[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells]. | |||
*The progression to [disease name] usually involves the [molecular pathway]. | |||
*The pathophysiology of [disease/malignancy] depends on the histological subtype. | |||
==Genetics== | |||
[Disease name] is transmitted in [mode of genetic transmission] pattern. | |||
OR | |||
Genes involved in the pathogenesis of [disease name] include: | |||
*[Gene1] | |||
*[Gene2] | |||
*[Gene3] | |||
OR | |||
The development of [disease name] is the result of multiple genetic mutations such as: | |||
*[Mutation 1] | |||
*[Mutation 2] | |||
*[Mutation 3] | |||
==Associated Conditions== | |||
==Gross Pathology== | |||
On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name]. | |||
==Microscopic Pathology== | |||
On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name]. | |||
==References== | |||
{{Reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
[[Category: (name of the system)]] | |||
{{Glucose-6-phosphate dehydrogenase deficiency}} | {{Glucose-6-phosphate dehydrogenase deficiency}} | ||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] | {{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] |
Revision as of 13:55, 7 August 2018
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Glucose-6-phosphate dehydrogenase deficiency pathophysiology On the Web |
American Roentgen Ray Society Images of Glucose-6-phosphate dehydrogenase deficiency pathophysiology |
FDA on Glucose-6-phosphate dehydrogenase deficiency pathophysiology |
CDC on Glucose-6-phosphate dehydrogenase deficiency pathophysiology |
Glucose-6-phosphate dehydrogenase deficiency pathophysiology in the news |
Blogs on Glucose-6-phosphate dehydrogenase deficiency pathophysiology |
Risk calculators and risk factors for Glucose-6-phosphate dehydrogenase deficiency pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The exact pathogenesis of [disease name] is not fully understood.
OR
It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
OR
[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
OR
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
OR
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
OR
The progression to [disease name] usually involves the [molecular pathway].
OR
The pathophysiology of [disease/malignancy] depends on the histological subtype.
Pathophysiology
Physiology
The normal physiology of [name of process] can be understood as follows:
Pathogenesis
- The exact pathogenesis of [disease name] is not completely understood.
OR
- It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
- [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
- Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
- [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
- The progression to [disease name] usually involves the [molecular pathway].
- The pathophysiology of [disease/malignancy] depends on the histological subtype.
Genetics
[Disease name] is transmitted in [mode of genetic transmission] pattern.
OR
Genes involved in the pathogenesis of [disease name] include:
- [Gene1]
- [Gene2]
- [Gene3]
OR
The development of [disease name] is the result of multiple genetic mutations such as:
- [Mutation 1]
- [Mutation 2]
- [Mutation 3]
Associated Conditions
Gross Pathology
On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Microscopic Pathology
On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
References
Glucose-6-phosphate dehydrogenase deficiency Microchapters |
Differentiating Glucose-6-phosphate dehydrogenase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glucose-6-phosphate dehydrogenase deficiency pathophysiology On the Web |
American Roentgen Ray Society Images of Glucose-6-phosphate dehydrogenase deficiency pathophysiology |
FDA on Glucose-6-phosphate dehydrogenase deficiency pathophysiology |
CDC on Glucose-6-phosphate dehydrogenase deficiency pathophysiology |
Glucose-6-phosphate dehydrogenase deficiency pathophysiology in the news |
Blogs on Glucose-6-phosphate dehydrogenase deficiency pathophysiology |
Directions to Hospitals Treating Glucose-6-phosphate dehydrogenase deficiency |
Risk calculators and risk factors for Glucose-6-phosphate dehydrogenase deficiency pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [3]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Pathophysiology